Boardroom Alpha
Boardroom Alpha
FVN · Additional Proxy Materials (DEFA14A) · Filed August 18, 2026

Future Vision II Acquisition Corp — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
August 18, 2026
Ticker
FVN
Accession
0001829126-26-008993
Boardroom Alpha · Filing insights

Future Vision II clarifies Extension EGM redemption mechanics; new LOI and DWAC required by Aug 19, 2026.

About Future Vision II Acquisition Corp
Market cap
$71M
1Y TSR
+9.9%
Sector
Industrials
CEO
Xiaodong Wang
Last annual meeting: Aug 21, 2026 · View full Future Vision II Acquisition Corp profile →

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 7, 2026

 

 

 

Future Vision II Acquisition Corp.

(Exact name of registrant as specified in its charter)

 

 

 

Cayman Islands   001-42273   00-0000000N/A

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

Xiandai Tongxin Building

201 Xin Jinqiao Road, Rm 302

Pudong New District

Shanghai, China00000

(Address of principal executive offices, including zip code)

 

+ (86) 136 0300 0540

(Registrant’s telephone number, including area code)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Ordinary Share, par value $0.0001 per share, and one right to acquire 1/10th of one Ordinary Share   FVNNU   The Nasdaq Stock Market LLC
Ordinary Shares included as part of the Units   FVN   The Nasdaq Stock Market LLC
Rights included as part of the Units   FVNNR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 8.01 Other Events.

 

Future Vision II Acquisition Corp. (the “Company”) is providing clarifying information to its shareholders, broker-dealers, and clearing firms regarding the redemption mechanics for its upcoming extraordinary general meeting of shareholders (the “Extension EGM”).

 

The purpose of the Extension EGM is to seek shareholder approval of a proposal to further extend the date by which the Company must consummate an initial business combination. For additional details regarding the Extension EGM, shareholders and investors should refer to the definitive proxy statement filed by the Company with the Securities and Exchange Commission on August 7, 2026 (the “Proxy Statement”).

 

The Company wishes to clarify that the redemption event associated with the Extension EGM is separate from, and not mutually exclusive with, the redemption event associated with the Company’s extraordinary general meeting related to its initial business combination held on July 23, 2026 (the “July 23 EGM”).

 

The redemption window for the July 23 EGM has closed. Shareholders should note that any redemption instructions or Letters of Intent (LOIs) submitted in connection with the July 23 EGM will not automatically roll over or apply to the Extension EGM.

 

If a shareholder wishes to elect to redeem their Ordinary Shares in connection with the upcoming Extension EGM, such shareholder or their broker must take separate, affirmative action to complete both of the following steps no later than 5:00 p.m. Eastern Time on August 19, 2026 (the “Redemption Deadline”):

 

1.Submit a new written request (Letter of Intent) to the Company’s transfer agent specifically designating the redemption of shares for the Extension EGM; and

 

2.Deliver the specific shares covered by the new written request to the transfer agent’s account at The Depository Trust Company (DTC) electronically utilizing the Deposit/Withdrawal at Custodian (DWAC) system so that such shares are registered on the Company's books.

 

FAILURE TO COMPLETE BOTH OF THE AFOREMENTIONED STEPS BY THE AUGUST 19, 2026 REDEMPTION DEADLINE WILL RESULT IN THE APPLICABLE SHARES NOT BEING ELIGIBLE FOR REDEMPTION IN CONNECTION WITH THE EXTENSION EGM.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.   Description of Exhibits
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Future Vision II Acquisition Corp.
     
Date: August 18, 2026 By: /s/ Danhua Xu
  Name: Danhua Xu
  Title: CEO and Director

 

2

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Future Vision II Acquisition Corp (FVN)

Reference

Frequently asked questions

When did Future Vision II Acquisition Corp file this DEFA14A?
Future Vision II Acquisition Corp (FVN) filed this Additional Proxy Materials (DEFA14A) with the SEC on August 18, 2026. The accession number assigned by EDGAR is 0001829126-26-008993.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Future Vision II clarifies Extension EGM redemption mechanics; new LOI and DWAC required by Aug 19, 2026. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Future Vision II Acquisition Corp's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Future Vision II Acquisition Corp has filed under CIK 2010653, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer